OpenURL Connection Search

Select item for more details and to access through your institution.

AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 567, doi. 10.1002/hon.15_2632
By:
- Kim, W.S.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Budde, L.E.;
- Cheah, C.;
- Gregory, G.P.;
- Hong, J.;
- Ku, M.;
- Marlton, P.;
- Matasar, M.;
- Nastoupil, L.;
- Panizo, C.;
- Sehn, L.H.;
- Tzachanis, D.;
- Chu, W.;
- Hernandez, M.G.;
- Kwan, A.;
- Li, C.C.;
- Sison, I.
Publication type:
Article
ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 564, doi. 10.1002/hon.12_2632
By:
- Budde, L.E.;
- Vallurupalli, A.;
- Babu, S.;
- Lossos, I.S.;
- Alderuccio, J.P.;
- Chavez, J.C.;
- Eradat, H.;
- Holmes, H.;
- Hamadani, M.;
- Karur, V.G.;
- Olszewski, A.J.;
- Seymour, E.;
- Althaus, B.;
- Medeiros, B.M.;
- Li, C.C.;
- Kwan, A.;
- Wei, M.C.;
- Yin, S.;
- O'Hear, C.;
- Munoz, J.
Publication type:
Article
AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 567, doi. 10.1002/hon.15_2632
By:
- Kim, W.S.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Budde, L.E.;
- Cheah, C.;
- Gregory, G.P.;
- Hong, J.;
- Ku, M.;
- Marlton, P.;
- Matasar, M.;
- Nastoupil, L.;
- Panizo, C.;
- Sehn, L.H.;
- Tzachanis, D.;
- Chu, W.;
- Hernandez, M.G.;
- Kwan, A.;
- Li, C.C.;
- Sison, I.
Publication type:
Article
ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 564, doi. 10.1002/hon.12_2632
By:
- Budde, L.E.;
- Vallurupalli, A.;
- Babu, S.;
- Lossos, I.S.;
- Alderuccio, J.P.;
- Chavez, J.C.;
- Eradat, H.;
- Holmes, H.;
- Hamadani, M.;
- Karur, V.G.;
- Olszewski, A.J.;
- Seymour, E.;
- Althaus, B.;
- Medeiros, B.M.;
- Li, C.C.;
- Kwan, A.;
- Wei, M.C.;
- Yin, S.;
- O'Hear, C.;
- Munoz, J.
Publication type:
Article
BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON-BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 81, doi. 10.1002/hon.2437_69
By:
- Park, S.I.;
- Olajide, O.;
- Reddy, N.M.;
- Budde, L.E.;
- Ghosh, N.;
- Richards, K.L.;
- Deal, A.M.;
- Noe, J.F.;
- Shea, T.C.;
- Ansell, S.M.
Publication type:
Article

Found: 5

AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.

ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL).

AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.

ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL).

BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON-BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL.